oxybutynin has been researched along with Heart Diseases in 2 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Heart Diseases: Pathological conditions involving the HEART including its structural and functional abnormalities.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Toda, H | 1 |
| Nakamura, K | 1 |
| Shimizu, K | 1 |
| Ejiri, K | 1 |
| Iwano, T | 1 |
| Miyoshi, T | 1 |
| Nakagawa, K | 1 |
| Yoshida, M | 1 |
| Watanabe, A | 1 |
| Nishii, N | 1 |
| Hikasa, Y | 1 |
| Hayashi, M | 1 |
| Morita, H | 1 |
| Morimatsu, H | 1 |
| Ito, H | 1 |
| Wijeysundera, DN | 1 |
| Choi, PT | 1 |
| Badner, NH | 1 |
| Brasher, PM | 1 |
| Dresser, GK | 1 |
| Delgado, DH | 1 |
| Beattie, WS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The EPIC (Evaluating Perioperative Ischemia Reduction by Clonidine) Study: A Randomized, Double-blinded Trial of Clonidine for Reducing Cardiac Morbidity and Mortality Following Non-cardiac Surgery.[NCT00335582] | Phase 4 | 165 participants (Anticipated) | Interventional | 2006-06-30 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for oxybutynin and Heart Diseases
| Article | Year |
|---|---|
Effects of Bisoprolol Transdermal Patches for Prevention of Perioperative Myocardial Injury in High-Risk Patients Undergoing Non-Cardiac Surgery　- Multicenter Randomized Controlled Study.
Topics: Administration, Cutaneous; Adrenergic beta-1 Receptor Antagonists; Aged; Aged, 80 and over; Biomarke | 2020 |
A randomized feasibility trial of clonidine to reduce perioperative cardiac risk in patients on chronic beta-blockade: the EPIC study.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Canada; Clonidine; Double-Blind Method; Dru | 2014 |